JOURNEY STRATEGIC WEALTH LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1909316 SUMMIT, NJ

Position in VRTX

as of Mar 31, 2026 · filed Apr 15, 2026 Compact

Position Value

$956,931

+$303,643 QoQ

Shares Held

2,143

+48.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 0% Shared 98% None 2%

Healthcare · as of Mar 31, 2026

JOURNEY STRATEGIC WEALTH LLC holds $11,646,586 across 14 Biotechnology names. VRTX ranks #3 (8.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc.	12,829	$6,715,596
2	REGN	Regeneron Pharmaceuticals, Inc.	1,572	$1,214,585
3	VRTX	Vertex Pharmaceuticals Inc / Ma This page	2,143	$956,931
4	ZYME	Zymeworks Inc.	29,050	$727,410
5	EXEL	Exelixis, Inc.	7,252	$311,035
6	INCY	Incyte Corp	3,272	$307,958
7	ARWR	Arrowhead Pharmaceuticals, Inc.	4,546	$285,033
8	JAZZ	Jazz Pharmaceuticals plc	1,305	$246,708

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$956,931	2,143	+48.7%	Shares	Sole	2026-04-15
2025-12-31	$653,288	1,441	+51.0%	Shares	Sole	2026-02-13
2025-09-30	$373,621	954	-40.5%	Shares	Sole	2025-11-12
2025-06-30	$713,653	1,603	+101.9%	Shares	Sole	2025-08-12
2025-03-31	$384,944	794	+10.0%	Shares	Sole	2025-05-06
2024-12-31	$290,746	722	-7.8%	Shares	Sole	2025-01-24
2024-09-30	$364,156	783	+48.3%	Shares	Sole	2024-11-12
2024-06-30	$247,482	528	-26.3%	Shares	Sole	2024-08-14
2023-03-31	$225,590	716	-24.6%	Shares	Sole	2023-05-12
2022-12-31	$274,339	950	+37.1%	Shares	Sole	2023-02-14
2022-09-30	$200,650	693	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.